Atlas Trials

Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization

Clinical trial NCT00508742 · COMPLETED

Trial details

NCT number
NCT00508742
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pneumococcal Infections
Start date
2007-12-01
Primary completion
2011-08-01
Enrollment
1866

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.